MoneyWorks4Me

Concord Drugs - Quaterly Results

11 Aug 2026 Evaluate
A decent increase of about 56.13% in the turnover to Rs. 208.97 millions was observed for the quarter ended June 2026. The turnover stood at Rs. 133.84 millions during the similar quarter previous year.Net Profit for the quarter ended June 2026 zoomed to 892.86% from Rs. 1.12 millions to Rs. 11.12  millions.OP of the company witnessed a marginal growth to 22.41 millions from 9.39 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 208.97 133.84 56.13 208.97 133.84 56.13 758.83 369.46 105.39
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT 22.41 9.39 138.66 22.41 9.39 138.66 42.64 37.77 12.89
Interest 3.51 4.20 -16.43 3.51 4.20 -16.43 14.59 17.18 -15.08
PBDT 18.90 5.19 264.16 18.90 5.19 264.16 28.05 20.59 36.23
Depreciation 3.48 3.66 -4.92 3.48 3.66 -4.92 13.57 14.18 -4.30
PBT 15.42 1.53 907.84 15.42 1.53 907.84 14.48 6.41 125.90
TAX 4.30 0.41 948.78 4.30 0.41 948.78 4.11 3.46 18.79
Deferred Tax -0.11 -0.11 0.00 -0.11 -0.11 0.00 -0.02 1.56 -101.28
PAT 11.12 1.12 892.86 11.12 1.12 892.86 10.37 2.95 251.53
Equity 131.75 100.00 31.75 131.75 100.00 31.75 131.75 100.00 31.75
PBIDTM(%) 10.72 7.02 52.85 10.72 7.02 52.85 5.62 10.22 -45.03
Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..